Anpario (LON:ANP) Sets New 12-Month High – What’s Next?

Anpario plc (LON:ANPGet Free Report) reached a new 52-week high during trading on Monday . The stock traded as high as GBX 580 and last traded at GBX 569.88, with a volume of 11124 shares changing hands. The stock had previously closed at GBX 562.22.

Wall Street Analyst Weigh In

A number of brokerages recently commented on ANP. Canaccord Genuity Group upped their price target on shares of Anpario from GBX 550 to GBX 570 and gave the company a “buy” rating in a research note on Thursday, January 22nd. Shore Capital Group reaffirmed a “house stock” rating on shares of Anpario in a report on Monday, January 19th. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, Anpario currently has an average rating of “Buy” and a consensus target price of GBX 570.

View Our Latest Report on ANP

Anpario Stock Up 1.4%

The company has a market cap of £96.57 million, a PE ratio of 19.17 and a beta of 0.58. The stock has a 50-day moving average of GBX 512.25 and a 200-day moving average of GBX 485.43. The company has a quick ratio of 5.16, a current ratio of 6.15 and a debt-to-equity ratio of 0.10.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Further Reading

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.